1. Home
  2. TROX vs GOSS Comparison

TROX vs GOSS Comparison

Compare TROX & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$4.92

Market Cap

680.2M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.54

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
GOSS
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.2M
796.2M
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
TROX
GOSS
Price
$4.92
$2.54
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$4.69
$8.60
AVG Volume (30 Days)
4.9M
4.5M
Earning Date
02-11-2026
11-05-2025
Dividend Yield
4.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,844,000,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.02
$6.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$0.76
52 Week High
$10.60
$3.87

Technical Indicators

Market Signals
Indicator
TROX
GOSS
Relative Strength Index (RSI) 68.68 32.83
Support Level $4.08 $3.04
Resistance Level $4.30 $3.87
Average True Range (ATR) 0.21 0.28
MACD 0.01 -0.13
Stochastic Oscillator 93.86 0.74

Price Performance

Historical Comparison
TROX
GOSS

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: